Evidence map›Paper›PMID 32531819›Full record

ArticleJournal of surgical oncology2020

Post-discharge venous thromboembolism after pancreatectomy for malignancy: Predicting risk based on preoperative, intraoperative, and postoperative factors.

Cary Jo R Schlick, Ryan P Merkow, Anthony D Yang, David J Bentrem

Open access · greenAbstract read
In one paragraph

Article in Journal of surgical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Venous thromboembolism following surgery for pancreatic neuroendocrine neoplasms.Research and practice in thrombosis and haemostasis · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Development and validation of a risk calculator for post-discharge venous thromboembolism following hepatectomy for malignancy.HPB : the official journal of the International Hepato Pancreato Biliary Association · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Cary Jo R SchlickDepartment of Surgery, Surgical Outcomes and Quality Improvement Center (SOQIC), Feinberg School of Medicine, Northwestern University, Chicago, Illinois.ORCID http://orcid.org/0000-0003-4944-8896
Ryan P MerkowDepartment of Surgery, Surgical Outcomes and Quality Improvement Center (SOQIC), Feinberg School of Medicine, Northwestern University, Chicago, Illinois.ORCID http://orcid.org/0000-0002-8752-4653
Anthony D YangDepartment of Surgery, Surgical Outcomes and Quality Improvement Center (SOQIC), Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
David J BentremDepartment of Surgery, Surgical Outcomes and Quality Improvement Center (SOQIC), Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Northwestern University · US

Funding

PA-20-072: Supplement to A Chicago Center of Excellence in Learning Health Systems Research Training (ACCELERAT)K12HS026385 · AHRQ · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FRANKLIN, PATRICIA D, KHO, ABEL N. · 2018 to 2022
$3.4M
Tailored Adaptation of the AHRQ VTE QI Guide to Local Hospital Context.K08HL145139 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI YANG, ANTHONY D. · 2019 to 2023
$800k
Directed evaluation of provider learning modules to prevent venous thromboembolism after major cancer surgeryI01HX002290 · VA · JESSE BROWN VA MEDICAL CENTER · PI BENTREM, DAVID J · 2018 to 2021
–
Agency for Healthcare Research and Quality K12HS026385AHRQ HHS K12 HS026385American Cancer Society IRG-18-163-24HSRD VA I01 HX002290National Heart, Lung and Blood Institute K08HL145139NHLBI NIH HHS K08 HL145139Veteran's Administration I01HX002290
6 · The paper itself

Abstract

BACKGROUND AND

objectivesExtended chemoprophylaxis is recommended for high-risk patients following pancreatectomy for malignancy. However, quantifying risk remains difficult. We sought to (a) identify factors associated with post-discharge venous thromboembolism (VTE) following pancreatectomy for malignancy and (b) develop a post-discharge VTE risk calculator to identify high-risk patients.

methodsPatients who underwent pancreatectomy for malignant histology from 2014 to 2018 were identified from the ACS NSQIP pancreatectomy procedure targeted dataset. Preoperative, intraoperative, and postoperative factors known at hospital discharge were evaluated for association with post-discharge VTE via multivariable logistic regression. A post-discharge VTE risk calculator was developed and validated.

resultsOf 19 340 analyzed patients, 280 (1.5%) developed post-discharge VTE. Post-discharge VTE was associated with increasing body mass index (BMI; eg, morbidly obese BMI odds ratio [OR]: 1.99 [95% confidence interval {CI}: 1.30-3.02] vs normal BMI), procedure type (distal pancreatectomy OR: 1.47 [95% CI: 1.02-2.12] vs pancreaticoduodenectomy), pancreatic fistula (OR: 1.59 [95% CI: 1.19-2.13]) and delayed gastric emptying (OR: 1.81 [95% CI: 1.29-2.52]). Patients' predicted probability of post-discharge VTE ranged from 0.7% to 9.0%. Twenty iterations of 10-fold cross-validation demonstrated internal validity.

conclusionsPreoperative, intraoperative, and postoperative factors were associated with post-discharge VTE following pancreatectomy for malignancy. This post-discharge VTE risk calculator allows for quantification of individual post-discharge VTE risk, which ranged from 0.7% to 9.0%.

Indexed as

ACS NSQIPextended chemoprophylaxispancreatectomypost-discharge venous thromboembolismrisk calculatorvenous thromboembolism

Identifiers

PMID32531819
PMCPMC7755307
OpenAlexW3034734780

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.